Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure

In recent years, several market pressures have caused a shift in market outlook for orthopedic biomaterial products. Although the market continues to grow year over year, average selling prices (ASPs) are declining as a result of these pressures. Our research shows that these ASPs are declining at a rate of nearly 5 percent annually across particular segments of this market.

Despite declining prices, technological innovation and other developments have maintained the market’s growth, drawing in patients with easier-to-perform and more efficient procedures. However, manufacturers may need to shift strategies as prices continue to decline.

This article was originally published on meddeviceonline.com, read the full article here.

For Further Information

More on the orthopedic biomaterials market in the U.S. can be found in a series of reports published by iData entitled the U.S. Market Report Suite for Orthopedic Biomaterials.